Cargando…
Tocilizumab reverses cerebral vasculopathy in a patient with homozygous SAMHD1 mutation
An auto-inflammatory syndrome consequent to SAMHD1 mutations involves cerebral vasculopathy characterized by multifocal stenosis and aneurysms within large arteries, moyamoya, chronic ischemia, and early-onset strokes (SAMS). While this condition involves the innate immune system, additional clinica...
Autores principales: | Henrickson, Michael, Wang, Heng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer London
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5486483/ https://www.ncbi.nlm.nih.gov/pubmed/28289923 http://dx.doi.org/10.1007/s10067-017-3600-2 |
Ejemplares similares
-
Aggressive CD8(+) epidermotropic cutaneous T-cell lymphoma associated with homozygous mutation in SAMHD1
por: Merati, Miesha, et al.
Publicado: (2015) -
SAMHD1 Gene Mutations Are Associated with Cerebral Large-Artery Atherosclerosis
por: Li, Wei, et al.
Publicado: (2015) -
Glucocorticoid-resistant polymyalgia rheumatica: pretreatment characteristics and tocilizumab therapy
por: Mori, Shunsuke, et al.
Publicado: (2014) -
A complex COVID-19 case with rheumatoid arthritis treated with tocilizumab
por: Cai, Shaozhe, et al.
Publicado: (2020) -
Tocilizumab in the Treatment of Eosinophilic Fasciitis: A Case Study and Review of Literature
por: El Iskandarani, Sarah, et al.
Publicado: (2023)